A Phase III Study of Infliximab and Corticosteroids for the Initial Treatment of Acute Graft-versus-Host Disease

Anti-Tumor Necrosis Factor Alpha (TNF-α) therapy with infliximab has shown to be effective for patients with steroid-refractory acute graft-versus-host disease (aGVHD). An open-labeled, phase III trial was conducted to determine if the addition of infliximab to steroids could improve results for pat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Couriel, Daniel R., Saliba, Rima, de Lima, Marcos, Giralt, Sergio, Andersson, Borje, Khouri, Issa, Hosing, Chitra, Ippoliti, Cindy, Shpall, Elizabeth J., Champlin, Richard, Alousi, Amin
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4114035/
https://ncbi.nlm.nih.gov/pubmed/19896079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2009.08.003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares